Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Dendritic cell mitochondrial regulation axis refers to the integrated metabolic and signaling network that controls mitochondrial function, biogenesis, and dynamics to dictate the functional state of dendritic cells (DCs). In their quiescent state, DCs rely on oxidative phosphorylation (OXPHOS) for energy; however, upon encountering pathogens or inflammatory signals, they undergo a rapid metabolic switch to aerobic glycolysis, a process essential for the biosynthetic demands of maturation and cytokine production (Pearce & Everts, 2015). This axis is governed by key regulatory molecules such as PGC-1α, which promotes mitochondrial biogenesis, and AMPK, which senses energy status and modulates metabolic flux (Malinarich et al., 2015). In the context of the tumor microenvironment, this axis is often suppressed by tumor-derived factors, leading to DC metabolic exhaustion and impaired anti-tumor T-cell responses (Zhao et al., 2020). Conversely, overactive mitochondrial metabolism in DCs can drive pathological inflammation in autoimmune disorders. Therapeutic strategies targeting this axis involve using small molecules like AMPK activators or PPARγ agonists to restore mitochondrial health in exhausted DCs for cancer immunotherapy or to inhibit specific metabolic checkpoints to treat inflammatory conditions (Sim et al., 2020).
Modulation of mitochondrial bioenergetics, biogenesis, and metabolic reprogramming to regulate dendritic cell maturation and immunological activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell mitochondrial regulation axis.